Engaged in biopharmaceutical development, this company focuses on the formulation of protein-based therapies, aiming to enhance drug delivery and stability for various medical applications.
2007
United Kingdom
11 - 50 employees
Biotechnology
$1M - 10M in revenue
Not profitable
CO2e per visit (g)
Industry benchmark